Based on Rayanakorn K et al., “The Effect of Kratom (Mitragyna speciosa) on Metabolic Parameters: A Systematic Review and Meta-Analysis,” Front Pharmacol. 2025;16:1587528, and Weiss ST, Douglas M., “Treatment of Kratom Use Disorder with Buprenorphine/Naloxone: Case Series and Dosing Recommendations,” J Addict Med. 2021;15(6):495–500.*
Kratom (Mitragyna speciosa), a tropical plant native to Southeast Asia, has sparked global debate for its mix of potential therapeutic benefits and public-health risks.
While some use it to relieve pain, anxiety, or opioid withdrawal, others are increasingly presenting with dependence, withdrawal, or toxicity that mirror opioid use disorder.
The question is no longer whether kratom has effects; it’s whether those effects can be safely managed and responsibly understood.
Why It Matters
Scientific findings are deeply divided. A 2025 meta-analysis found that long-term kratom use may improve metabolic health by lowering LDL cholesterol, triglycerides, and BMI.
However, a 2021 clinical case series reported patients who developed kratom use disorder and required buprenorphine/naloxone treatment for withdrawal and stabilization. The cases highlight that kratom’s “natural” label does not protect against dependence or withdrawal risk.
In the absence of regulation or standardized dosing, kratom’s pharmacologic unpredictability remains a significant concern for both clinicians and public health practitioners, as self-medication can quickly shift from relief to risk.
Key Takeaways
- At low doses, kratom can act as a mild stimulant and mood enhancer.
- At higher doses, it produces sedative, opioid-like effects and carries dependence potential.
- Withdrawal symptoms may mirror opioid withdrawal and respond to buprenorphine treatment.
- Clinicians should routinely screen for kratom use in patients with unexplained sedation, withdrawal, or negative toxicology screens despite opioid-like presentations.
Clinical Pearl:
Kratom can behave like an opioid at higher doses. Always consider it when opioid-like symptoms appear without confirmed opioid exposure.
Beyond the Mic
Kratom sits at the intersection of culture, commerce, and care. It reminds us that “natural” does not mean harmless and that meaningful conversations about safety require curiosity, compassion, and scientific clarity.
For clinicians, the key is not condemnation or casual endorsement but informed engagement; asking, educating, and guiding patients through evidence rather than assumption. Balanced, evidence-based conversations are the antidote to both stigma and sensationalism.
Featured Resources
- The Effect of Kratom on Metabolic Parameters: A Systematic Review and Meta-Analysis Rayanakorn K, Singhakant S, Kumdee K, Boonyamalik P, Sukkriang N. Front Pharmacol. 2025;16:1587528. doi:10.3389/fphar.2025.1587528 Read the full article on Frontiers in Pharmacology
- Kratom Use Disorder and Buprenorphine/Naloxone Treatment: Case Series and Dosing Recommendations Weiss ST, Douglas M. J Addict Med. 2021;15(6):495–500. doi:10.1097/ADM.0000000000000780 Read on PubMed
Listen to Transformed Minds: Kratom – Cure or Curse? To hear Dr. O unpack the science, controversies, and clinical implications behind this complex plant. FULL EPISODE
Stay ready. Stay aware. Stay grounded.
